![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 278 M $ as of 2026-05-30
Christopher Lai was the founder of AquaFresco, Inc., founded in 2015, and held the title of Chief Technology Officer.
Dr. Lai is the founder of Metis Pharmaceuticals, founded in 2019, and holds the titles of General Manager and Executive Director.
Dr. Lai is the founder of Metis TechBio Co., Ltd., founded in 2020, and holds the titles of Chairman and Chief Executive Officer.
Dr. Lai is also the founder of METiS Therapeutics, Inc...
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-12 | 111,166,572 ( 10.56% ) | 210 M $ | 2026-05-30 | |
METIS TECHBIO CO., LTD. 36.55% | 2026-05-12 | 36,400,278 ( 36.55% ) | 69 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| METIS TECHBIO CO., LTD. | Chief Executive Officer | 2020-01-09 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Chief Executive Officer | - |
Metis Pharmaceuticals
 Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform | Founder | 2018-12-31 |
| Companies | Position | End |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
Metis Pharmaceuticals
Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform | Health Technology |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
Select your edition
All financial news and data tailored to specific country editions
